{"title":"Association of Selected Biochemical Markers and Body Mass Index in Women with Endocrine Disorders","authors":"M. Mydl\u00e1rov\u00e1 Bla\u0161\u010d\u00e1kov\u00e1, J. Bernasovsk\u00e1, J. Por\u00e1\u010dov\u00e1, I. Boro\u0148ov\u00e1","volume":93,"journal":"International Journal of Bioengineering and Life Sciences","pagesStart":592,"pagesEnd":596,"ISSN":"1307-6892","URL":"https:\/\/publications.waset.org\/pdf\/9999421","abstract":"<p>Obesity is frequent attendant phenomenon of patients<br \/>\r\nwith endocrinological disease. Between BMI and endocrinological<br \/>\r\ndiseases is close correlation. In thesis we focused on the allocation of<br \/>\r\nhormone concentration &ndash; PTH and TSH, CHOL a mineral element Ca<br \/>\r\nin a blood serum. The examined group was formed by 100<br \/>\r\nrespondents (women) aged 36 &ndash; 83 years, who were divided into two<br \/>\r\ngroups &ndash; control group (CG), group with diagnosed endocrine disease<br \/>\r\n(DED). The concentration of PTH and TSH, Ca and CHOL was<br \/>\r\nmeasured through the medium of analyzers Cobas e411 (Japan);<br \/>\r\nCobas Integra 400 (Switzerland). At individuals was measured body<br \/>\r\nweight as well as stature and thereupon from those data we<br \/>\r\nenumerated BMI. On the basis of Student T-test in biochemical<br \/>\r\nparameter of PTH and Ca we found out significantly meaningful<br \/>\r\ndifference (p&lt;0,05) between CG and DED. In CG we made a<br \/>\r\nfounding the association between BMI and PTH by means of<br \/>\r\ncorrelation analysis.<\/p>\r\n","references":"[1] J. \u010c\u00e1p, \"Onemocnen\u00ed hypotalamu a neurohypof\u00fdzy,\u201d Postgradu\u00e1ln\u00ed\r\nmedic\u00edna, vol. 15, no. 7, pp. 701, July 2013.\r\n[2] M. J. Bolland, A. B. Grey, G. D. Gamble, I. R. Reid, \"Association\r\nbetween primary hyperparathyroidism and increased body weight: a\r\nmetaanalysis,\" J Clin Endocrinol Metab., vol. 90, no. 3, pp. 1525\u20131530,\r\nMarch 2005.\r\n[3] V. Zamrazil, \"Nemoci \u0161t\u00edtne \u017el\u00e1zy v klinick\u00e9 praxi,\u201d Postgradu\u00e1ln\u00ed\r\nmedic\u00edna, vol. 15, no. 7, pp. 720 \u2013 729, July 2013.\r\n[4] G. Boden, G. I. Shulman, \"Free fatty acids in obesity and type 2 diabetes:\r\ndefining their role in the development of insulin resistance and beta-cell\r\ndysfunction,\u201d Eur J Clin Invest., vol. 32, no. 3, pp. 14 \u2013 23, March 2002.\r\n[5] T. Zima, A. Kazda, R. Pr\u016f\u0161a, P. \u0160tern, M. Aschermann, M. Babjuk et al.,\r\n\"Laborat\u00f3rni diagnostika\u201d 3. vyd. Praha: Gal\u00e9n, 2013, p. 906, ISBN\r\n978-80-7492-062-2.\r\n[6] Ch. Dreschler, D. C. Grootendorst, E. W. Boeschten, R. T.\r\nKrediet, Ch. Wanner, F. W. Dekker, \"Changes in parathyroid\r\nhormone and body mass index and association with mortality in\r\ndialysis patients,\u201d Nephrol Dial Transplant., vol. 19, no. 26, pp.\r\n1340 \u2013 1346, Sept. 2011.\r\n[7] A. Duk\u00e1t, \"Metabolick\u00fd syndr\u00f3m predstavuje dnes jeden z\r\nnajd\u00f4le\u017eitej\u0161\u00edch probl\u00e9mov s\u00fa\u010dasnej medic\u00edny,\u201d S\u00fa\u010d klin pr., vol. 3, p. 2-\r\n4, Sept. 2004.\r\n[8] M. Roden, \u201eMetabolic syndrom: a new epidemic? How to manage\r\ndiabetes and cardiovascular diseases,\" 3rd International Meeting on\r\nOutcomes in Diabetes, Istanbul, Turkey. 15-16 November 2007.\r\n[9] J. Jurkovi\u010dov\u00e1, \u013d. \u00c1ghov\u00e1, Z. \u0160tef\u00e1nikov\u00e1, \"Perception of risk in\r\nrelation to prevalence of cardiovascular disease risk factor in selected\r\npopulation group,\u201d Homeostasis, vol. 40, no. 3 \u2013 4, p. 139 \u2013 141, April\r\n2000.\r\n[10] D. Dobrota, et al., \"Lek\u00e1rska bioch\u00e9mia,\u201d. 1. vyd. Martin: Osveta, 2012,\r\np. 723, ISBN 978-80-8063-293-9.\r\n[11] E. Kamycheva, J. Sundsfjord, R. Jorde, \u201eSerum parathyroid\r\nhormone level is associated with body mass index,\u201d Eur J\r\nEndocrinol., vol. 151, no. 2, pp. 167 \u2013 172, Feb. 2004.\r\n[12] C. P. Kovesdy, S. Ahmadzadeh, J. E. Anderson, K. Kalantar-Zadeh,\r\n\"Obesity is associated with secondary hyperparathyroidism,\u201d Clin J Am\r\nSoc Nephrol., vol. 5 no. 2, p. 1024-1029, Sept. 2007.\r\n[13] A. Solanki, S. Bansal, S. Jidal, V. Saxena, U. S. Shukla, \"Relationship\r\nof serum thyroid stimulating hormone with body mass index in\r\nhealthy adults,\u201d Indian J Endocrinol Metab., vol. 17, no. 7, pp. 167 \u2013\r\n169, Oct 2013.\r\n[14] C. M. Kitahara, E. A. Platz, P. W. Ladenson, A. M. Mondul, A.\r\nMenke, A. B. Gonz\u00e1lez, \u201dBody Fatness and Markers of thyroid\r\nfunction among U.S. men and women,\u201d Plos One, vol. 7, no. 4, pp.\r\n1 \u2013 6, April 2012.\r\n[15] L. Mehran, A. Amouzegar, H. Deshad, F. Azizi, \"Association between\r\nserum TSH concentration and body mass index in euthyroid\r\nsubject,\u201d Arch Iran Med., vol. 15, no. 7, pp. 400-403, July 2012.\r\n[16] A. Milionis, Ch. Milionis, \"Correlation between body mass index\r\nand thyroid function in euthyroid individuals in Greece.\u201d Online.\r\nAvailable: http:\/\/dx.doi.org\/10.1155\/2013\/651494, May2014.","publisher":"World Academy of Science, Engineering and Technology","index":"Open Science Index 93, 2014"}